MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Habenula Volume in Mood Disorders in Parkinson’s Disease

    B. Samanci, Y. Temel, M. Kuijf, S. Tan, S. Michielse (Maastricht, Netherlands)

    Objective: To assess whether dysregulation of habenula (Hb) contributes to mood disorders in Parkinson’s disease (PD). Background: PD is often accompanied by mood disorders, such…
  • 2023 International Congress

    Evoking Parkinsonism in Mice by a Pharmacological Approach Combined with Targeted Viral-based Manipulations of Neuronal Ensembles

    C. Agua Villa, H. Siebner, M. Rickhag (Hvidovre, Denmark)

    Objective: We implement a pharmacological approach for eliciting dopamine deprivation using transient blockage of dopamine signaling to replicate core parkinsonian motor symptoms. Background: Parkinson’s disease…
  • 2023 International Congress

    Development of a health-related quality-of-life (HR-QoL) questionnaire for hereditary spastic paraplegia (HSP) patients and caregivers.

    J. Malina, E-M. Hüßler, B. Schröder, N. Wiesenberg, T. Kühl, S. Klebe (Essen, Germany)

    Objective: The aim of this project is to develop and validate a health-related quality-of-life (HR-QoL) questionnaire, in a patient and a caregiver version, specific for…
  • 2023 International Congress

    15-year effects of initiating treatment for Parkinson’s disease with dopamine agonists or monoamine oxidase B inhibitors compared with levodopa: final results of PD MED early disease randomisation

    C. Clarke, C. Rick, S. Patel, R. Wooley, N. Rowland, J. Futterer, R. Ottridge, C. Jenkinson, R. Gray (Birmingham, United Kingdom)

    Objective: PD MED EARLY is a large, pragmatic trial aiming to determine which class of drug as initial treatment provides the most effective long-term control…
  • 2023 International Congress

    The effect of lumboperitoneal shunt surgery on patients with iNPH plus Parkinson’s disease

    T. Tsunemi, T. Shimada, A. Sakukrai, M. Nakajima, N. Hattori (Toyoo, Japan)

    Objective: To investigate the effect of lumboperitoneal shunt surgery on patients with iNPH comorbid with Parkinson’s disease Background: Comorbid Parkinson’s disease (PD) in idiopathic normal…
  • 2023 International Congress

    Differential Spatiotemporal Gait Effects with Frequency and Dopaminergic Modulation in STN-DBS

    R. Ramdhani, J. Watts, M. Klein, T. Fitzpatrick, M. Niethammer, A. Khojandi (Great Neck, USA)

    Objective: The purpose of this study is to determine whether low frequency (LFS; 60Hz) STN-DBS elicits a differential response to high frequency (HFS;180hz) in spatiotemporal…
  • 2023 International Congress

    Network attack tolerance: A resilience proxy for Parkinson’s disease?

    A. Asendorf, A. Temizyürek, M. Banwinkler, V. Dzialas, THE. Parkinson-Progression-Marker-Initiative, T. van Eimeren, M. Hoenig (Cologne, Germany)

    Objective: To investigate if individual capacity in network attack tolerance moderates the relationship between striatal dopamine loss and symptom severity in PD. Background: It was…
  • 2023 International Congress

    Eye tracking paradigm to identify disease-specific behavioral biomarkers in neurodegeneration

    M. Habibi, B. Coe, D. Brien, H. Riek, A. Janzen, W. Oertel, D. Munoz (Marburg, Germany)

    Objective: Rapid-eye movement (REM) sleep behavior disorder (RBD) has been identified as the most specific and common prodromal stages of α-synucleinopathies (αSYN) such as Parkinson's…
  • 2023 International Congress

    Genetic and functional analysis of CCDC88C mutations in patients with Parkinson’s disease.

    S. Chen, J. Chen, X. Xie, W. Luo (Hangzhou, China)

    Objective: To investigate the association between rare deleterious CCDC88C variants and PD. Background: SCA40 is a rare form of spinocerebellar ataxia caused by heterozygous mutations…
  • 2023 International Congress

    Double trouble: dystonic tremor due to FXTAS in a SCA1 family

    P. Santurelli, G. Bonato, R. Polli, A. Murgia, M. Carecchio (Padova, Italy)

    Objective: To describe a patient belonging to a SCA1 family, who presented with action tremor and dysmetria but with a different genetic etiology. Background: Spino-Cerebellar…
  • « Previous Page
  • 1
  • …
  • 146
  • 147
  • 148
  • 149
  • 150
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley